Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors.

[1]  K. Sekiguchi,et al.  Laminin Isoforms Containing the γ3 Chain Are Unable to Bind to Integrins due to the Absence of the Glutamic Acid Residue Conserved in the C-terminal Regions of the γ1 and γ2 Chains* , 2008, Journal of Biological Chemistry.

[2]  R. Kramer,et al.  Laminin Isoforms of Lymph Nodes and Predominant Role of ␣5- Laminin(s) in Adhesion and Migration of Blood Lymphocytes Physiology and Pharmacology, And , 2022 .

[3]  H. Naganuma,et al.  Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of α5-laminin(s) and α3β1 integrin , 2007 .

[4]  E. Nice,et al.  Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. , 2007, The American journal of pathology.

[5]  C. Lugassy,et al.  Angiotropic Melanoma and Extravascular Migratory Metastasis: A Review , 2007, Advances in anatomic pathology.

[6]  Alexander Nyström,et al.  Laminin isoforms in development and disease , 2007, Journal of Molecular Medicine.

[7]  D. Jackson,et al.  Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas , 2007, Cell and Tissue Research.

[8]  K. Sekiguchi,et al.  Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin–integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins , 2006 .

[9]  K. Tryggvason,et al.  Characterization of commercial laminin preparations from human placenta in comparison to recombinant laminins 2 (α2β1γ1), 8 (α4β1γ1), 10 (α5β1γ1) , 2006 .

[10]  J. Sanes,et al.  A simplified laminin nomenclature. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[11]  K. Sekiguchi,et al.  Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. , 2005, Neoplasia.

[12]  J. Miner,et al.  Laminin functions in tissue morphogenesis. , 2004, Annual review of cell and developmental biology.

[13]  B. Fadeel,et al.  An endothelial laminin isoform, laminin 8 (α4β1γ1), is secreted by blood neutrophils, promotes neutrophil migration and extravasation, and protects neutrophils from apoptosis , 2004 .

[14]  T. Tsuji Physiological and Pathological Roles of α3β1 Integrin , 2004, The Journal of Membrane Biology.

[15]  Yihai Cao,et al.  Deletion of Laminin-8 Results in Increased Tumor Neovascularization and Metastasis in Mice , 2004, Cancer Research.

[16]  D. Massi,et al.  Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. , 2004, Human pathology.

[17]  David Polsky,et al.  Focus on melanoma. , 2002, Cancer cell.

[18]  K. Tryggvason,et al.  Chondroitin sulphate modification in the α4 chain of human recombinant laminin-8 (α4β1γ1) , 2002 .

[19]  K. Sekiguchi,et al.  Localization of Laminin α4-Chain in Developing and Adult Human Tissues , 2002 .

[20]  K. Tryggvason,et al.  Laminin isoforms in tumor invasion, angiogenesis and metastasis. , 2002, Seminars in cancer biology.

[21]  R. Timpl,et al.  Recombinant human laminin-10 (alpha5beta1gamma1). Production, purification, and migration-promoting activity on vascular endothelial cells. , 2002, The Journal of biological chemistry.

[22]  R. Timpl,et al.  Recombinant Human Laminin-10 (α5β1γ1) , 2002, The Journal of Biological Chemistry.

[23]  R. Timpl,et al.  Domain IVa of laminin α5 chain is cell‐adhesive and binds β1 and αVβ3 integrins through Arg‐Gly‐Asp , 2001 .

[24]  P. Meltzer,et al.  Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. , 2001, Cancer research.

[25]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[26]  C. Lugassy,et al.  Melanoma and extravascular migratory metastasis , 2000, Journal of cutaneous pathology.

[27]  T. Kiviluoto,et al.  Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. , 2000, Experimental cell research.

[28]  K. Tryggvason,et al.  Chain specificity assignment of monoclonal antibodies to human laminins by using recombinant laminin β1 and γ1 chains , 2000 .

[29]  R. Kramer,et al.  Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[30]  M. Marinkovich,et al.  Melanocytes adhere to and synthesize laminin‐5 in vitro , 1999, Experimental dermatology.

[31]  J. Woodruff,et al.  Expression of basement membrane antigens in spindle cell melanoma , 1998, Journal of cutaneous pathology.

[32]  K. Sekiguchi,et al.  Isolation and Characterization of Laminin-10/11 Secreted by Human Lung Carcinoma Cells , 1998, The Journal of Biological Chemistry.

[33]  L. Happerfield,et al.  Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. , 1998, British Journal of Cancer.

[34]  V. Morris,et al.  An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. , 1997, Cancer research.

[35]  R. Kramer,et al.  Laminin 5 deposition promotes keratinocyte motility. , 1996, Experimental cell research.

[36]  M. Herlyn,et al.  Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. , 1995, Cancer research.

[37]  K. Tryggvason,et al.  Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. , 1995, Cancer research.

[38]  D. Noonan,et al.  The α3β1 Integrin Is Involved in Melanoma Cell Migration and Invasion , 1995 .

[39]  M. Aumailley,et al.  Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors , 1994, The Journal of cell biology.

[40]  E. Danen,et al.  Emergence of α5β1 fibronectin‐ and αvβ3 vitronectin‐receptor expression in melanocytic tumour progression , 1994 .

[41]  D. Schadendorf,et al.  Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours , 1993, The Journal of pathology.

[42]  A. Bartolazzi,et al.  Integrin expression in cutaneous malignant melanoma: Association of the α3/β1 heterodimer with tumor progression , 1993 .

[43]  P. Natali,et al.  Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor , 1991 .

[44]  R. Burgeson,et al.  Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments , 1991, The Journal of cell biology.

[45]  D. Elder,et al.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.

[46]  R. Kramer,et al.  Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. , 1990, Cancer research.

[47]  L. Liotta,et al.  The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.

[48]  V. Dixit,et al.  Production and utilization of extracellular matrix components by human melanocytes. , 1989, Experimental cell research.

[49]  E. Kohn,et al.  Insulin-like growth factors stimulate chemotaxis in human melanoma cells. , 1988, Biochemical and biophysical research communications.

[50]  R. Ruddon,et al.  Laminin production by murine melanoma cells: possible involvement in cell motility , 1986, Clinical & Experimental Metastasis.

[51]  P. Natali,et al.  Distribution of laminin and collagen type‐IV in benign and malignant lesions of melanocytic origin , 1985, International journal of cancer.

[52]  L. Liotta,et al.  Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. , 1984, Science.

[53]  J. McCarthy,et al.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro , 1984, The Journal of cell biology.

[54]  M. Bronner‐Fraser,et al.  Abnormalities in neural crest cell migration in laminin alpha5 mutant mice. , 2006, Developmental biology.

[55]  M. Bronner‐Fraser,et al.  Abnormalities in neural crest cell migration in laminin α5 mutant mice , 2006 .

[56]  T. Tsuji Physiological and pathological roles of alpha3beta1 integrin. , 2004, The Journal of membrane biology.

[57]  T. Irimura,et al.  Regulation of melanoma cell migration and invasion by laminin-5 and α3β1 integrin (VLA-3) , 2004, Clinical & Experimental Metastasis.

[58]  T. Irimura,et al.  Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). , 2002, Clinical & experimental metastasis.

[59]  R. Kramer,et al.  Transfection of MCF-7 carcinoma cells with human integrin alpha7 cDNA promotes adhesion to laminin. , 2001, Archives of biochemistry and biophysics.

[60]  R. Cancedda,et al.  Melanocytes lie on the epidermal basement membrane where they closely interact with surrounding basal ker- atinocytes to form a functional structure defined as the epi- dermal-melanin unit (Weiss and Greep, 1977). Melanocytes protect keratinocytes against ultraviolet damage (such as photocarcinogene , 1999 .

[61]  D. Noonan,et al.  The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. , 1995, Experimental cell research.

[62]  A. Sonnenberg,et al.  Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. , 1993, Cell adhesion and communication.

[63]  A. Bartolazzi,et al.  Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. , 1993, International journal of cancer.

[64]  P. Natali,et al.  Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. , 1991, International journal of cancer.